Projects funded by the NCN
Mitofusins as determinants of the resistance of glioblastoma multiforme cells to doxorubicin
2021/41/N/NZ3/02823
Keywords:
Glioma Doxorubicin Metabolism Mitofusins Mitochondria
Descriptors:
- NZ3_001:
- NZ3_002:
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 207 101 PLN
Project start date (Y-m-d): 2022-01-13
Project end date (Y-m-d): 2026-01-12
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stressAuthors:Maciej Pudełek, Damian Ryszawy, Katarzyna Piwowarczyk, Sławomir Lasota, Zbigniew Madeja, Sylwia Kędracka-Krok, Jarosław CzyżAcademic press:Journal of Translational Medicine (rok: 2024, tom: 22, strony: nie dotyczy), Wydawca: BMC, Springer NatureStatus:PublishedDOI:10.1186/s12967-024-05541-9 - link to the publication